# Kisspeptin Administration in the Adult

> **NCT00914823** · PHASE1 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 256 (actual)

## Conditions studied

- Hypogonadotropic Hypogonadism
- Kallmann Syndrome
- GnRH Deficiency
- PCOS
- Polycystic Ovarian Syndrome
- Hyperprolactinemia

## Interventions

- **DRUG:** kisspeptin 112-121
- **DRUG:** GnRH

## Key facts

- **NCT ID:** NCT00914823
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06-23
- **Primary completion:** 2021-10-22
- **Final completion:** 2021-10-22
- **Target enrollment:** 256 (ACTUAL)
- **Last updated:** 2024-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00914823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00914823, "Kisspeptin Administration in the Adult". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00914823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*